Skip to main content
NCBI home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1996 Oct;72(5):330–333. doi: 10.1136/sti.72.5.330

Is oral contraceptive associated with genital warts?

J D Ross 1
PMCID: PMC1195698  PMID: 8976847

Abstract

OBJECTIVE: To measure the association between oral contraceptive use and the prevalence of genital warts in women. METHODS: Cross sectional case control study comparing oral contraceptive use in women with and without genital warts attending a city centre genitourinary medicine clinic controlling for recent sexual activity, the presence of other sexually transmitted infections, socio-economic class and history of pregnancy using a multivariate logistic regression model. RESULTS: After controlling for potential confounding variables women with genital warts were significantly more likely to be current users of the oral contraceptive pill (OR 1.7, 95% CI 1.3-2.2). CONCLUSION: The study suggests that women taking the oral contraceptive may be at increased risk of presenting with genital warts. Previously published papers provide some support for this hypothesis and potential biological mechanisms are discussed.

Full text

PDF
330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes E. W., MacCuish A. C., Loudon N. B., Jordan J., Irvine W. J. Phytohaemagglutinin-induced lymphocyte transformation and circulating autoantibodies in women taking oral contraceptives. Lancet. 1974 May 11;1(7863):898–900. doi: 10.1016/s0140-6736(74)90348-1. [DOI] [PubMed] [Google Scholar]
  2. Bauer H. M., Hildesheim A., Schiffman M. H., Glass A. G., Rush B. B., Scott D. R., Cadell D. M., Kurman R. J., Manos M. M. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis. 1993 Sep-Oct;20(5):274–278. doi: 10.1097/00007435-199309000-00007. [DOI] [PubMed] [Google Scholar]
  3. Blackwell A. L., Thomas P. D., Wareham K., Emery S. J. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet. 1993 Jul 24;342(8865):206–210. doi: 10.1016/0140-6736(93)92299-9. [DOI] [PubMed] [Google Scholar]
  4. Brisson J., Morin C., Fortier M., Roy M., Bouchard C., Leclerc J., Christen A., Guimont C., Penault F., Meisels A. Risk factors for cervical intraepithelial neoplasia: differences between low- and high-grade lesions. Am J Epidemiol. 1994 Oct 15;140(8):700–710. doi: 10.1093/oxfordjournals.aje.a117318. [DOI] [PubMed] [Google Scholar]
  5. Cuzick J., De Stavola B., McCance D., Ho T. H., Tan G., Cheng H., Chew S. Y., Salmon Y. M. A case-control study of cervix cancer in Singapore. Br J Cancer. 1989 Aug;60(2):238–243. doi: 10.1038/bjc.1989.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Daling J. R., Sherman K. J., Weiss N. S. Risk factors for condyloma acuminatum in women. Sex Transm Dis. 1986 Jan-Mar;13(1):16–18. doi: 10.1097/00007435-198601000-00004. [DOI] [PubMed] [Google Scholar]
  7. Delgado-Rodriguez M., Sillero-Arenas M., Martin-Moreno J. M., Galvez-Vargas R. Oral contraceptives and cancer of the cervix uteri. A meta-analysis. Acta Obstet Gynecol Scand. 1992 Jul;71(5):368–376. doi: 10.3109/00016349209021075. [DOI] [PubMed] [Google Scholar]
  8. Eluf-Neto J., Booth M., Muñoz N., Bosch F. X., Meijer C. J., Walboomers J. M. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer. 1994 Jan;69(1):114–119. doi: 10.1038/bjc.1994.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Garzetti G. G., Ciavattini A., Provinciali M., Fabris N., Cignitti M., Romanini C. Natural killer cell activity in endometriosis: correlation between serum estradiol levels and cytotoxicity. Obstet Gynecol. 1993 May;81(5 ):665–668. [PubMed] [Google Scholar]
  10. Gloss B., Bernard H. U., Seedorf K., Klock G. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J. 1987 Dec 1;6(12):3735–3743. doi: 10.1002/j.1460-2075.1987.tb02708.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Grossman C. J. Regulation of the immune system by sex steroids. Endocr Rev. 1984 Summer;5(3):435–455. doi: 10.1210/edrv-5-3-435. [DOI] [PubMed] [Google Scholar]
  12. Harris R. W., Brinton L. A., Cowdell R. H., Skegg D. C., Smith P. G., Vessey M. P., Doll R. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer. 1980 Sep;42(3):359–369. doi: 10.1038/bjc.1980.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hildesheim A., Gravitt P., Schiffman M. H., Kurman R. J., Barnes W., Jones S., Tchabo J. G., Brinton L. A., Copeland C., Epp J. Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sex Transm Dis. 1993 Sep-Oct;20(5):279–285. doi: 10.1097/00007435-199309000-00008. [DOI] [PubMed] [Google Scholar]
  14. Irwin K. L., Rosero-Bixby L., Oberle M. W., Lee N. C., Whatley A. S., Fortney J. A., Bonhomme M. G. Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association? JAMA. 1988 Jan 1;259(1):59–64. [PubMed] [Google Scholar]
  15. Lehtinen M., Dillner J., Knekt P., Luostarinen T., Aromaa A., Kirnbauer R., Koskela P., Paavonen J., Peto R., Schiller J. T. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ. 1996 Mar 2;312(7030):537–539. doi: 10.1136/bmj.312.7030.537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Massé R., Laperrière H., Rousseau H., Lefebvre J., Remis R. S. Chlamydia trachomatis cervical infection: prevalence and determinants among women presenting for routine gynecologic examination. CMAJ. 1991 Oct 15;145(8):953–961. [PMC free article] [PubMed] [Google Scholar]
  17. McCance D. J. Cervical cancer. News on papillomaviruses. Nature. 1988 Oct 27;335(6193):765–766. doi: 10.1038/335765a0. [DOI] [PubMed] [Google Scholar]
  18. Molina R., Thomas D. B., Dabancens A., Lopez J., Ray R. M., Martinez L., Salas O. Oral contraceptives and cervical carcinoma in situ in Chile. Cancer Res. 1988 Feb 15;48(4):1011–1015. [PubMed] [Google Scholar]
  19. Negrini B. P., Schiffman M. H., Kurman R. J., Barnes W., Lannom L., Malley K., Brinton L. A., Delgado G., Jones S., Tchabo J. G. Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix. Cancer Res. 1990 Aug 1;50(15):4670–4675. [PubMed] [Google Scholar]
  20. Parazzini F., la Vecchia C., Negri E., Maggi R. Oral contraceptive use and invasive cervical cancer. Int J Epidemiol. 1990 Jun;19(2):259–263. doi: 10.1093/ije/19.2.259. [DOI] [PubMed] [Google Scholar]
  21. Pater M. M., Hughes G. A., Hyslop D. E., Nakshatri H., Pater A. Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA. Nature. 1988 Oct 27;335(6193):832–835. doi: 10.1038/335832a0. [DOI] [PubMed] [Google Scholar]
  22. Smith J. R., Murdoch J., Carrington D., Frew C. E., Dougall A. J., MacKinnon H., Baillie D., Byford D. M., Forrest C. A., Davis J. A. Prevalence of Chlamydia trachomatis infection in women having cervical smear tests. BMJ. 1991 Jan 12;302(6768):82–84. doi: 10.1136/bmj.302.6768.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ursin G., Peters R. K., Henderson B. E., d'Ablaing G., 3rd, Monroe K. R., Pike M. C. Oral contraceptive use and adenocarcinoma of cervix. Lancet. 1994 Nov 19;344(8934):1390–1394. doi: 10.1016/s0140-6736(94)90567-3. [DOI] [PubMed] [Google Scholar]
  24. Weiss N. S., Sayvetz T. A. Incidence of endometrial cancer in relation to the use of oral contraceptives. N Engl J Med. 1980 Mar 6;302(10):551–554. doi: 10.1056/NEJM198003063021004. [DOI] [PubMed] [Google Scholar]
  25. Wheeler C. M., Parmenter C. A., Hunt W. C., Becker T. M., Greer C. E., Hildesheim A., Manos M. M. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis. 1993 Sep-Oct;20(5):286–289. doi: 10.1097/00007435-199309000-00009. [DOI] [PubMed] [Google Scholar]
  26. Yaffee H. S. Recalcitrant condyloma acuminatum. N Engl J Med. 1969 Jul 31;281(5):274–274. doi: 10.1056/NEJM196907312810522. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES